therapeutics

Converse of object

• develop: Professor Duncan has become the first person in the world to develop polymer therapeutics for clinical trial.
• base: I say this as someone whose practice is based on stage hypnosis techniques rather than psychologically based therapeutics.
• include: The web pages include a summary of ophthalmology programs and services including experimental therapeutics.

Preposition: for

• treatment: Edison is partnered with leading academic centers and foundations to develop first-in-class therapeutics for the treatment of these diseases.
• disease: CAT and Elan are working together to produce novel antibody-based therapeutics for certain human neurological diseases.

Adjective modifier

• gene-based: Research & Development Pipeline Oxford BioMedica is developing novel gene-based therapeutics in the fields of cancer, virus infection and neurodegenerative disease.
• antibody-based: CAT will also receive rights to develop antibody-based therapeutics to certain selected targets provided by Lilly.
• anti-cancer: This process is a known target for anti-cancer therapeutics.
• targeted: The remaining three years of their time at the center will be spent working on research projects centered on the theme of targeted therapeutics.
• novel: CAT and Elan are working together to produce novel antibody-based therapeutics for certain human neurological diseases.
• biological: CAT will become central to AstraZeneca's plans to establish a major international presence in the research and development of biological therapeutics.

Modifies a noun

• committee: The BAPEN guidance has been used by some Drug and therapeutics committees locally in Scotland to prepare guidelines.
• company: The Company: Is a leading human therapeutics company in the biotechnology industry.
• market: The emerging non-Hodgkins lymphoma therapeutics market generated more that $ 1 billion USD in revenues in 2000.

Noun used with modifier

• monoclonal: CAT will receive royalty payments on sales of any human monoclonal antibody therapeutics that Enzon and Micromet successfully develop using CAT's intellectual property.
• antibody: However, the need for ' fully ' human antibody therapeutics remained.
• novel: She is part of a local research collaboration developing novel therapeutics targeting regulators of tumor invasion.
• cancer: The proteins examined are relevant pharmacological targets in field of cancer therapeutics.
• protein: Current awareness of the medical applications of protein therapeutics.
• molecule: Oxford BioMedica has also agreed to develop screens for small molecule therapeutics for RPR.